The main treatment for PD currently involves levodopa (L-DOPA), a precursor of dopamine, combined with a COMT inhibitor (tolcapone, entacapone or opicapone), or a MAOB inhibitor (rasagiline, selegiline, safinamide or zonisamide). This evidence concerns the gene COMT and Parkinson disease.